Whitehawk Therapeutics Investor Relations Material
Latest events
Fireside Chat
Whitehawk Therapeutics
Q2 2025
7 Aug, 2025
Corporate Presentation
7 Aug, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Whitehawk Therapeutics Inc.
Access all reports
Aadi Bioscience Inc. is a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers and other serious diseases. The company's lead product is designed to target specific mutations in the mTOR pathway, a key regulator of cell growth and survival. The company is headquartered in Pacific Palisades, California, and its shares are listed on the NASDAQ.
Key slides for Whitehawk Therapeutics Inc.
Investor Update
Whitehawk Therapeutics Inc.
Q1 2025
Whitehawk Therapeutics Inc.
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
WHWK
Country
🇺🇸 United States